ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,327Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 1844

$1.06M Total Retail Price of All Prescriptions

Rank: 37 out of 1844

501 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 501 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 501 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 15,230 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 792 695 1 3
HYDROCODONE-ACETAMINOPHEN 749 466 S3 2 2
OMEPRAZOLE 715 601 3 5
LISINOPRIL 636 536 4 4
WARFARIN SODIUM 495 444 5 13
FUROSEMIDE 447 416 6 7
AMLODIPINE BESYLATE 414 390 7 6
ATENOLOL 404 347 8 17
LEVOTHYROXINE SODIUM 391 336 9 1
METFORMIN HCL 388 306 10 8
ATORVASTATIN CALCIUM 363 337 11 12
POTASSIUM CHLORIDE 349 320 12 16
HYDROCHLOROTHIAZIDE 240 222 13 9
METOPROLOL SUCCINATE 225 218 14 14
GABAPENTIN 218 128 15 15
NAMENDA 188 177 16 33
RAMIPRIL 184 172 17 116
CLONIDINE HCL 183 166 18 64
ALENDRONATE SODIUM 176 163 19 25
DONEPEZIL HCL 170 158 20 26
TAMSULOSIN HCL 161 125 21 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 160 157 22 20
DICLOFENAC SODIUM 157 119 23 122
MELOXICAM 147 126 24 28
GLYBURIDE 146 134 R 25 100
PREDNISONE 145 128 26 40
ALLOPURINOL 144 125 27 29
METOPROLOL TARTRATE 139 138 28 11
CRESTOR 138 116 29 30
PAROXETINE HCL 137 95 30 68
GLIMEPIRIDE 135 100 31 35
ZOLPIDEM TARTRATE 133 102 32 23
CYMBALTA 130 116 33 36
POLYETHYLENE GLYCOL 3350 130 119 33 39
NEXIUM 127 74 35 31
CITALOPRAM HBR 121 107 36 19
TRIAMTERENE-HCTZ 118 102 37 48
AMOXICILLIN 116 97 38 101
CLOPIDOGREL 112 92 39 34
CIPROFLOXACIN HCL 109 98 40 62
CEPHALEXIN 108 87 41 56
LOSARTAN POTASSIUM 104 83 42 24
AMITRIPTYLINE HCL 99 76 R 43 72
DIGOXIN 97 97 44 67
SPIRIVA 96 75 45 57
ZETIA 94 74 46 81
ISOSORBIDE MONONITRATE ER 93 79 47 59
LEVOFLOXACIN 91 78 48 78
DILTIAZEM 24HR CD 91 91 48 132
QUINAPRIL HCL 90 82 50 152
AMLODIPINE BESYLATE-BENAZEPRIL 85 76 51 80
DILTIAZEM ER 84 82 52 200
ADVAIR DISKUS 84 62 52 51
LANTUS 83 63 54 42
AZITHROMYCIN 82 63 55 37
CARVEDILOL 80 46 56 22
PLAVIX 80 73 56 61
PRAVASTATIN SODIUM 78 52 58 10
BENAZEPRIL HCL 78 74 58 75
BYSTOLIC 76 68 60 106
SYNTHROID 75 63 61 55
PANTOPRAZOLE SODIUM 74 63 62 32
PROAIR HFA 70 43 63 45
TRAZODONE HCL 69 34 64 43
SERTRALINE HCL 67 42 65 21
DOXAZOSIN MESYLATE 67 67 65 110
ZOSTAVAX 66 62 67 237
MIRTAZAPINE 64 64 68 49
DOXYCYCLINE HYCLATE 64 58 68 90
LOSARTAN-HYDROCHLOROTHIAZIDE 63 42 70 47
OXYBUTYNIN CHLORIDE ER 61 59 71 126
SYMBICORT 61 50 71 134
DIOVAN 61 58 71 58
SOTALOL 61 61 71 361
JANUVIA 61 57 71 77
ESCITALOPRAM OXALATE 61 59 71 52
BENICAR 61 61 71 218
EVISTA 58 58 78 95
FLUTICASONE PROPIONATE 58 46 78 50
KLOR-CON M20 57 52 80 54
RISPERIDONE 56 29 81 65
ENALAPRIL MALEATE 56 34 81 69
VENTOLIN HFA 55 42 83 145
QUETIAPINE FUMARATE 54 18 84 82
COMBIVENT 53 45 85 131
IBUPROFEN 53 12 85 89
LIPITOR 53 51 85 159
FELODIPINE ER 52 52 88 230
TRAMADOL HCL-ACETAMINOPHEN 51 50 89 159
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 43 89 73
METHOTREXATE 50 50 91 292
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 3, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.